+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Attention Deficit Disorder"

From
Europe Mental Wellness Market Outlook, 2029 - Product Thumbnail Image

Europe Mental Wellness Market Outlook, 2029

  • Report
  • March 2024
  • 65 Pages
  • Europe
From
From
From
From
Stress & Anxiety in Times of Crises - Webinar (Recorded) - Product Thumbnail Image

Stress & Anxiety in Times of Crises - Webinar (Recorded)

  • Webinar
  • August 2022
  • 60 Minutes
  • Global
From
From
Mental Illness in the Workplace - Webinar (Recorded) - Product Thumbnail Image

Mental Illness in the Workplace - Webinar (Recorded)

  • Webinar
  • June 2018
  • 90 Minutes
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Attention Deficit Disorder (ADD) is a mental health disorder characterized by difficulty focusing, impulsivity, and hyperactivity. It is most commonly diagnosed in children, but can also affect adults. Symptoms of ADD can include difficulty paying attention, difficulty organizing tasks, restlessness, and impulsivity. Treatment for ADD typically includes medication, psychotherapy, and lifestyle changes. The Attention Deficit Disorder market is a subset of the larger Mental Health market. It is a growing market, with an increasing number of people seeking treatment for ADD. The market is expected to continue to grow as more people become aware of the disorder and seek treatment. Companies in the Attention Deficit Disorder market include Shire Pharmaceuticals, Novartis, and Eli Lilly. Other companies in the Mental Health market include Pfizer, Johnson & Johnson, and GlaxoSmithKline. Show Less Read more